Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Claire Bridel; Joep Killestein; Charlotte Teunissen

doi:https://doi.org/10.1212/WNL.0000000000200133

Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Claire Bridel, Joep Killestein, Charlotte Teunissen

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	471
Number of pages	1
Journal	Neurology
Volume	98
Issue number	11
DOIs	https://doi.org/10.1212/WNL.0000000000200133
Publication status	Published - 15 Mar 2022

Access to Document

https://doi.org/10.1212/WNL.0000000000200133

Cite this

@article{94223aa944424fd989011c753746b40f,

title = "Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis",

author = "Claire Bridel and Joep Killestein and Charlotte Teunissen",

year = "2022",

month = mar,

day = "15",

doi = "https://doi.org/10.1212/WNL.0000000000200133",

language = "English",

volume = "98",

pages = "471",

journal = "Neurology",

issn = "0028-3878",

publisher = "American Academy of Neurology",

number = "11",

}

TY - JOUR

T1 - Author Response

T2 - Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

AU - Bridel, Claire

AU - Killestein, Joep

AU - Teunissen, Charlotte

PY - 2022/3/15

Y1 - 2022/3/15

UR - http://www.scopus.com/inward/record.url?scp=85126709669&partnerID=8YFLogxK

U2 - https://doi.org/10.1212/WNL.0000000000200133

DO - https://doi.org/10.1212/WNL.0000000000200133

M3 - Comment/Letter to the editor

C2 - 35288476

SN - 0028-3878

VL - 98

SP - 471

JO - Neurology

JF - Neurology

IS - 11

ER -

Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Access to Document

Other files and links

Cite this